Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Other Non-Current Assets (2023 - 2026)

Beta Bionics' Other Non-Current Assets history spans 4 years, with the latest figure at $100000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $100000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $100000.0, a 0.0% change, with the full-year FY2025 number at $180000.0, down 96.44% from a year prior.
  • Other Non-Current Assets hit $100000.0 in Q1 2026 for Beta Bionics, down from $180000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BBNX hit a ceiling of $5.1 million in Q4 2024 and a floor of $100000.0 in Q4 2023.
  • Historically, Other Non-Current Assets has averaged $603100.0 across 4 years, with a median of $100000.0 in 2023.
  • Biggest five-year swings in Other Non-Current Assets: surged 4951.0% in 2024 and later tumbled 96.44% in 2025.
  • Tracing BBNX's Other Non-Current Assets over 4 years: stood at $100000.0 in 2023, then surged by 4951.0% to $5.1 million in 2024, then tumbled by 96.44% to $180000.0 in 2025, then plummeted by 44.44% to $100000.0 in 2026.
  • Business Quant data shows Other Non-Current Assets for BBNX at $100000.0 in Q1 2026, $180000.0 in Q4 2025, and $100000.0 in Q3 2025.